Koers High Hampton Holdings Corp Canadian Securities Exchange
Aandelen
CA42966X3094
Farmaceutische producten
Omzet 2022 | - | Omzet 2023 | - | Marktkapitalisatie | 563K 411K 384K |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | - 0 0 | Nettowinst (verlies) 2023 | - 0 0 | EV/omzet 2022 | - |
Nettoliquiditeiten 2022 | 841K 613K 573K | Nettoliquiditeiten 2023 | 690K 503K 470K | EV/omzet 2023 | - |
K/w-verhouding 2022 |
22,9
x | K/w-verhouding 2023 |
-8,18
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 79,53% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Robert Dubeau
CEO | Chief Executive Officer | - | 26-09-23 |
Director of Finance/CFO | 54 | 19-09-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director of Finance/CFO | 54 | 19-09-23 | |
Robert Dubeau
CEO | Chief Executive Officer | - | 26-09-23 |
Anderson Shannon
BRD | Director/Board Member | - | 19-09-23 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+33,25% | 699 mld. | |
+27,43% | 571 mld. | |
-3,55% | 364 mld. | |
+18,16% | 326 mld. | |
+4,36% | 286 mld. | |
+14,64% | 236 mld. | |
+4,45% | 198 mld. | |
-11,04% | 194 mld. | |
-5,59% | 154 mld. |